Krishna Institute of Medical Sciences

KIMS signs operations and management agreement with Ushahkal Abhinav Institute of Medical Sciences

Under the terms of the agreement, KIMS will receive a 9% revenue fee based on the hospital’s net revenue, calculated in accordance with Indian GAAP (excluding indirect taxes and other income).

KIMS Q3 FY25 results: Net profit jumps 81% YoY to Rs 319.3 crore, revenue increases 21% YoY

Showing strong financial performance despite increased costs. Profit After Tax (PAT) for Nine Months (FY24-25) amounted to ₹25.07 crore.

Krishna Institute of Medical Sciences (KIMS) shares rise 3% on Q2 results

HSBC initiates Buy call on KIMS, expects 20.7% upside in the stock price

HSBC has initiated coverage on Krishna Institute of Medical Sciences (KIMS) with a "Buy" rating and a target price of ₹3,300 per share, suggesting a 20.7% upside from the stock’s closing price of ₹2,734 on September 12.

Krishna Institute Of Medical Sciences enters into a long-term agreement with Sree Chand Specialty Hospital, Kannur

Stocks to watch today: Lupin, Vodafone Idea, L&T Tech and others

Stocks to watch today: The trading session on Tuesday will centre on shares of companies including Vodafone Idea, Lupin, L&T Tech, and others.